European Commission grants marketing authorisation for Trimbow® inhalation powder (beclometasone dipropionate, formoterol fumarate dihydrate and glycopyrronium) delivered through NEXThaler

This product is an extra fine formulation of triple fixed combination therapy in a single dry powder inhaler for the maintenance treatment of adult patients with moderate to severe COPD, which offers an alternative to the pressurised metered dose inhaler formulation.

Biospace Inc.